Anticoagulation polyvinyl chloride extracorporeal circulation catheters for heparin-free treatment
Guiliang Li,Haibo Lin,Fu Liu,Qiang Li,Gang Deng,yang liu,Han Qiu
DOI: https://doi.org/10.1039/d2tb01584f
IF: 7.571
2022-09-15
Journal of Materials Chemistry B
Abstract:Extracorporeal circulation (ECC) catheters are anticipated to be blood compatible to prevent thrombotic occlusion. Here, we massively produced heparin-mimicking anticoagulation PVC tubing by synthesizing heparin-mimicking polymers (HMPs) and co-extruding. The PVC@HMP catheter was evaluated by whole human blood in vitro, which indicated it could prevent plasma protein attachment, reduce platelet adhesion and activation, and inhibit coagulation factors (XII, XI, IX, and VIII). Moreover, the anticoagulation PVC tubing were assembled into extracorporeal circulation with a New Zealand rabbit, manifesting excellent real-time antithrombogenic properties without systemic heparin anticoagulation in vivo. The rapid recovery of coagulation factors after operation further confirms its superiority over heparin, that would not completely inactivate activity of those factors. In addition, the PVC@HMP-1 catheters remain patent after being implanted in rats for 28 days without apparent inflammation and mortality complications. The anticoagulation PVC tubes could construct various of systemic and integrative anticlotting biomedical devices, which dramatically reduce the introduction of heparin in blood circulation, thus preventing side effects and promoting the development of heparin-free treatment.
materials science, biomaterials